ExSight Ventures

Congratulations to the Elios Vision team on their execution and dedication to bringing this innovative technology forward. This is a remarkable accomplishment for the team and outcome for all stakeholders. Bausch + Lomb is a well suited to take this technology forward into commercialization. ExSight's 2021 Elios investment was not only a belief in the technology and the potential for the treatment of glaucoma but a vote in elliot friedman and Patrick Green. Thank you and congratulations to Elliot, Patrick, Cari Stone, Ike Ahmed, Frank Shields, and all other members of the team and those that have contributed to this accomplishment.

Horizon Surgical Systems raised $30M in Series A funding to revolutionize eye surgery with their Polaris system! Founded by Dr. Jean-Pierre Hubschman, Horizon is supported by ExSight Ventures, Main Street Advisors, and UC Investments. Their AI-powered robotics aim to make surgeries safer and more precise. Read the article news section on colaeb.com #EyeSurgery #Robotics #Innovation

We are thrilled to announce our continued support of Horizon Surgical Systems with the closing of a $30 million Series A financing. The technology being developed by founders Jean-Pierre Hubschman and Jacob Rosen will advance and transform ophthalmic surgery. The company has further strengthened their amazing team concurrent with this round. Read more on these new additions and financing: https://lnkd.in/esUY8DPb

Our Virtual Discussion is tonight, but there is still time to register! We’ll dive into Early Stage Ophthalmic Innovation. It’s a great opportunity to gain valuable insights and engage with industry experts. Don’t miss out! Register now: https://lnkd.in/eDBNVzf2 Feel free to share this with your network—let’s learn and grow together! hashtag #Webinar hashtag #IndustryInsights hashtag #LearnAndGrow hashtag #RegisterNow

Our Virtual Discussion is happening tomorrow, and we’re excited for what promises to be an engaging conversation. If you haven’t done so yet, please make sure to register to join us live or to receive the recording afterward. We look forward to having you with us! #virtualdiscussion #webinar #ophthalmology #innovation #venturecapital

Our Virtual Discussion is in 2 days, where we’ll dive into Early Stage Ophthalmic Innovation. It’s a great opportunity to gain valuable insights and engage with industry experts. Don’t miss out! Please LIKE this post if you plan to attend. Register now: https://lnkd.in/eDBNVzf2 Feel free to share this with your network—let’s learn and grow together! #Webinar #IndustryInsights #LearnAndGrow #RegisterNow

Congratulations to the ONL Therapeutics team, including David Esposito and David Zacks, for their dedication and leadership. Johnson & Johnson Innovation JJDC Inc and Marian Nakada, Ph.D. have been an excellent and supportive investor and an ideal partner to continue their support into the Phase 2 global study. We proudly backed ONL Therapeutics with our first fund back in 2018 and have continued our participation across numerous rounds, recognizing 1204's immense potential. It has been gratifying to have others recognize that same potential and promise as the team has taken this forward. We are thrilled to participate in this Series D financing as ONL Therapeutics moves ONL-1204 one step closer to "helping patients see the future."

We are just over a week away from our Virtual Discussion on Early Stage Ophthalmic Innovation. Can't make it to the live discussion? Anyone registered for the event will receive the recording via email after the conversation. Date: September 18, 2024 Time: 8:00 - 8:45 PM EST Use the link below to register. https://lnkd.in/eytyrbBa #virtualdiscussion #VentureCapital #Investing #Ophthalmology #webinar

Join ExSight Ventures' team of partners for an open conversation where we explore the evaluation process of early-stage ophthalmic innovations. Learn how our investment team identifies and invests in promising startups and discover how you can participate in similar opportunities through our Syndicates. Date: September 18, 2024 Time: 8:00 - 8:45 PM EST Use the link below to register.  https://lnkd.in/eytyrbBa